2019 IPO
Harpoon Therapeutics Stock
Harpoon Therapeutics is a preclinical stage biotechnology company.
Sign up today and learn more about Harpoon Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Harpoon Therapeutics Stock
Harpoon Therapeutics is a preclinical stage biotechnology company founded by MPM that is developing a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets.
Funding History
| April 2016 | $15.0M |
|---|---|
| May 2017 | $45.0M |
| November 2018 | $70.0M |
Management
Vice President
Che-Leung Law
CFO
William E. Picht
Co-Founder
Luke Evnin
President & CEO
Gerald McMahon
SENIOR VICE PRESIDENT
Holger Wesche
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
